Zobrazeno 1 - 10
of 45
pro vyhledávání: '"W M, Castle"'
Publikováno v:
BMJ. 306:1034-1037
OBJECTIVE--To compare safety of salmeterol and salbutamol in treating asthma. DESIGN--Double blind, randomised clinical trial in parallel groups over 16 weeks. SETTING--General practices throughout the United Kingdom. SUBJECTS--25,180 patients with a
Publikováno v:
European journal of anaesthesiology. Supplement. 6
Ondansetron is a novel 5-HT3 receptor antagonist used for the treatment of cytotoxic-induced emesis and postoperative nausea and vomiting. Safety data from volunteer studies, non-emesis development studies, studies in the treatment of cytotoxic-induc
Publikováno v:
Annals of Oncology. 3:773-774
Autor:
W. M. Castle
Publikováno v:
Pharmacoepidemiology & Drug Safety. 1:53-54
Publikováno v:
BMJ. 307:683-683
Autor:
W M Castle
Publikováno v:
Adverse Drug Reaction Bulletin. 113:420-423
Autor:
W M Castle
Publikováno v:
Adverse Drug Reaction Bulletin. 114:424-427
Autor:
W. M. Castle
Publikováno v:
Drug Information Journal. 20:323-326
Many outsiders do not appreciate the fact that it is not as easy to assess drug safety as drug efficacy. Among the problems in evaluating adverse experiences are the following: confusion over what ...